Archives

by in
Entry Author Date Location
Still Waiting for the Ships to Come in at Third Rock Ventures 03/28/13 San Diego
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round 03/01/13 Boston
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More 02/15/13 National
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Jounce Therapeutics Garners $47,000,000 Series A Financing Round 02/14/13 Boston
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Shire Buys Third Rock’s Lotus Tissue Repair 01/08/13 Boston
Bill Gates, Yuri Milner Join $13.5M Round For Foundation Medicine 01/08/13 Boston
Xconomist of the Week: Alexis Borisy Still Likes Early Stage Biotechs 12/20/12 Boston
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Zafgen Obtains $21,000,000 New Funding Round 12/04/12 Boston
How To Build a Biotech Cluster That Isn’t Boston or SF 11/20/12 National
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More 10/19/12 New York
Cibiem Obtains $10,000,000 Series A Financing 10/18/12 New York
Medical Device Company Cibiem Launches with $10 Million Series A 10/17/12 New York
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Boston Scientific, Foundation, GnuBio, & More in Boston Life Sciences News 09/21/12 Boston
Foundation Medicine Secures $42,500,000 Series B Financing 09/21/12 Boston
MyoKardia Receives $38,000,000 New Financing Round 09/21/12 San Francisco
Third Rock’s MyoKardia Gets $38M for Genetic Forms of Heart Disease 09/20/12 San Francisco
Page 5 of 13 « previous page · next page »